Trial: 201606146

A Phase IIa Study of BL-8040 in Combination with Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma

Phase

II

Principal Investigator

Uy, Geoffrey

Disease Site

Acute Lymphocytic Leukemia (ALL); Leukemia, other

Learn more about this study at: clinicaltrials.gov